TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of$ 0.45. This compares to loss of $0.46 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -13.33%. A quarter ago, it was expected that this company would post a loss of$ 0.48 per share when it actually produced a loss of $0.23, delivering a surprise of 52.08%. Over the last four quarters, the company has surpass ...